Skip to main content
Top
Published in: Neurocritical Care 2/2020

01-10-2020 | Stroke | Viewpoint

Low-Intensity Monitoring After Stroke Thrombolysis During the COVID-19 Pandemic

Authors: Roland Faigle, Brenda Johnson, Debbie Summers, Pooja Khatri, Craig S. Anderson, Victor C. Urrutia, for the OPTIMISTmain Steering Committee

Published in: Neurocritical Care | Issue 2/2020

Login to get access

Excerpt

The COVID-19 pandemic of 2020 poses an unprecedented challenge to health-care systems all across the USA and around the world. Supply and equipment shortages are already a daunting reality in many hospitals and imminent for others. Over the coming months, the projected intensive care unit (ICU) bed capacity gap in the USA ranges from 90,000 to 300,000, depending on infection rates and the success of social distancing and other measures to ‘flatten the curve’ [1, 2]. This is in excess of all available ICU beds, including those typically allocated to critically ill patients with stroke and other neurological diseases. In addition to material and equipment shortages, health-care personnel are becoming increasingly stretched as the pandemic continues, with neurology providers and nurses being repurposed or re-assigned, and others temporarily dropping out of the work-force for illness, self-isolation after exposure, or after becoming infected themselves. …
Appendix
Available only for authorised users
Literature
1.
go back to reference Tsai TC, Jacobson B, Jha AK. American hospital capacity and projected need for COVID-19 patient care. Health Affairs Blog. 2020. Tsai TC, Jacobson B, Jha AK. American hospital capacity and projected need for COVID-19 patient care. Health Affairs Blog. 2020.
2.
go back to reference Ranney ML, Griffeth V, Jha AK. Critical supply shortages—The need for ventilators and personal protective equipment during the Covid-19 pandemic. N Engl J Med. 2020. Ranney ML, Griffeth V, Jha AK. Critical supply shortages—The need for ventilators and personal protective equipment during the Covid-19 pandemic. N Engl J Med. 2020.
3.
go back to reference CARE AAFR. Joint Statement on Multiple Patients Per Ventilator SCCM, AARC, ASA, APSF, AACN, and CHEST Share Unified Message 2020. CARE AAFR. Joint Statement on Multiple Patients Per Ventilator SCCM, AARC, ASA, APSF, AACN, and CHEST Share Unified Message 2020.
4.
go back to reference Truog RD, Mitchell C, Daley GQ. The toughest triage—allocating ventilators in a pandemic. N Engl J Med. 2020. Truog RD, Mitchell C, Daley GQ. The toughest triage—allocating ventilators in a pandemic. N Engl J Med. 2020.
5.
go back to reference AHA. Preparing for Stroke and COVID-19: Open Discussion with Regional Colleagues. Videoconference call: AHA; April 1, 2020. AHA. Preparing for Stroke and COVID-19: Open Discussion with Regional Colleagues. Videoconference call: AHA; April 1, 2020.
6.
go back to reference Temporary Emergency Guidance to US Stroke Centers During the COVID-19 Pandemic. Stroke 2020. Temporary Emergency Guidance to US Stroke Centers During the COVID-19 Pandemic. Stroke 2020.
7.
go back to reference Faigle R, Butler J, Carhuapoma JR, et al. Safety trial of low-intensity monitoring after thrombolysis: optimal post Tpa-Iv monitoring in ischemic STroke (OPTIMIST). Neurohospitalist. 2020;10:11–5.CrossRef Faigle R, Butler J, Carhuapoma JR, et al. Safety trial of low-intensity monitoring after thrombolysis: optimal post Tpa-Iv monitoring in ischemic STroke (OPTIMIST). Neurohospitalist. 2020;10:11–5.CrossRef
8.
go back to reference Faigle R, Sharrief A, Marsh EB, Llinas RH, Urrutia VC. Predictors of critical care needs after IV thrombolysis for acute ischemic stroke. PLoS ONE. 2014;9:e88652.CrossRef Faigle R, Sharrief A, Marsh EB, Llinas RH, Urrutia VC. Predictors of critical care needs after IV thrombolysis for acute ischemic stroke. PLoS ONE. 2014;9:e88652.CrossRef
9.
go back to reference Khan S, Soto A, Marsh EB. resource allocation: stable patients remain stable 12–24 h post-tPA. Neurocrit Care. 2019. Khan S, Soto A, Marsh EB. resource allocation: stable patients remain stable 12–24 h post-tPA. Neurocrit Care. 2019.
10.
go back to reference Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American heart association/American stroke association. Stroke. 2019;50:e344–418.CrossRef Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American heart association/American stroke association. Stroke. 2019;50:e344–418.CrossRef
11.
go back to reference Alberts MJ, Latchaw RE, Selman WR, et al. Recommendations for comprehensive stroke centers: a consensus statement from the Brain Attack Coalition. Stroke. 2005;36:1597–616.CrossRef Alberts MJ, Latchaw RE, Selman WR, et al. Recommendations for comprehensive stroke centers: a consensus statement from the Brain Attack Coalition. Stroke. 2005;36:1597–616.CrossRef
12.
go back to reference Braimah J, Kongable G, Rapp K, et al. Nursing care of acute stroke patients after receiving rt-PA therapy: the NINDS rt-PA Stroke Study Group. J Neurosci Nurs. 1997;29:373–83.CrossRef Braimah J, Kongable G, Rapp K, et al. Nursing care of acute stroke patients after receiving rt-PA therapy: the NINDS rt-PA Stroke Study Group. J Neurosci Nurs. 1997;29:373–83.CrossRef
13.
go back to reference National Institute of Neurological D, Stroke rt PASSG. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581–7. National Institute of Neurological D, Stroke rt PASSG. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581–7.
14.
go back to reference Menon BK, Saver JL, Prabhakaran S, et al. Risk score for intracranial hemorrhage in patients with acute ischemic stroke treated with intravenous tissue-type plasminogen activator. Stroke. 2012;43:2293–9.CrossRef Menon BK, Saver JL, Prabhakaran S, et al. Risk score for intracranial hemorrhage in patients with acute ischemic stroke treated with intravenous tissue-type plasminogen activator. Stroke. 2012;43:2293–9.CrossRef
15.
go back to reference Wahlgren N, Ahmed N, Davalos A, et al. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet. 2007;369:275–82.CrossRef Wahlgren N, Ahmed N, Davalos A, et al. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet. 2007;369:275–82.CrossRef
16.
go back to reference Yaghi S, Boehme AK, Dibu J, et al. Treatment and outcome of thrombolysis-related hemorrhage: a multicenter retrospective study. JAMA Neurol. 2015;72:1451–7.CrossRef Yaghi S, Boehme AK, Dibu J, et al. Treatment and outcome of thrombolysis-related hemorrhage: a multicenter retrospective study. JAMA Neurol. 2015;72:1451–7.CrossRef
17.
go back to reference Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008;359:1317–29.CrossRef Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008;359:1317–29.CrossRef
18.
go back to reference Emberson J, Lees KR, Lyden P, et al. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet. 2014;384:1929–35.CrossRef Emberson J, Lees KR, Lyden P, et al. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet. 2014;384:1929–35.CrossRef
19.
go back to reference Faigle R, Marsh EB, Llinas RH, Urrutia VC, Gottesman RF. ICAT: a simple score predicting critical care needs after thrombolysis in stroke patients. Crit Care. 2016;20:26.CrossRef Faigle R, Marsh EB, Llinas RH, Urrutia VC, Gottesman RF. ICAT: a simple score predicting critical care needs after thrombolysis in stroke patients. Crit Care. 2016;20:26.CrossRef
20.
go back to reference Chang A, Llinas EJ, Chen K, Llinas RH, Marsh EB. Shorter intensive care unit stays? The majority of post-intravenous tPA (tissue-type plasminogen activator) symptomatic hemorrhages occur within 12 hours of treatment. Stroke. 2018;49:1521–4.CrossRef Chang A, Llinas EJ, Chen K, Llinas RH, Marsh EB. Shorter intensive care unit stays? The majority of post-intravenous tPA (tissue-type plasminogen activator) symptomatic hemorrhages occur within 12 hours of treatment. Stroke. 2018;49:1521–4.CrossRef
21.
go back to reference Smith EE, Fonarow GC, Reeves MJ, et al. Outcomes in mild or rapidly improving stroke not treated with intravenous recombinant tissue-type plasminogen activator: findings from Get With The Guidelines-Stroke. Stroke. 2011;42:3110–5.CrossRef Smith EE, Fonarow GC, Reeves MJ, et al. Outcomes in mild or rapidly improving stroke not treated with intravenous recombinant tissue-type plasminogen activator: findings from Get With The Guidelines-Stroke. Stroke. 2011;42:3110–5.CrossRef
Metadata
Title
Low-Intensity Monitoring After Stroke Thrombolysis During the COVID-19 Pandemic
Authors
Roland Faigle
Brenda Johnson
Debbie Summers
Pooja Khatri
Craig S. Anderson
Victor C. Urrutia
for the OPTIMISTmain Steering Committee
Publication date
01-10-2020
Publisher
Springer US
Published in
Neurocritical Care / Issue 2/2020
Print ISSN: 1541-6933
Electronic ISSN: 1556-0961
DOI
https://doi.org/10.1007/s12028-020-00998-0

Other articles of this Issue 2/2020

Neurocritical Care 2/2020 Go to the issue

A Day in the Life of a Neurocritical Care Trainee

A Change of Course: The Case for a Neurorecovery Clinic